The COPD Assessment Test (CAT) and Depression: A Longitudinal Analysis During the COVID-19 Pandemic

References

• Park HY, Chang Y, Kang D, et al. Blood eosinophil counts and the development of obstructive lung disease: the Kangbuk Samsung Health Study. Eur Respir J. 2021;58(4):2003823. doi:10.1183/13993003.03823-2020
   PubMed Web of Science ®Google Scholar
• Maurer J, Rebbapragada V, Borson S, et al. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest. 2008;134(4 Suppl):43S–56S. doi:10.1378/chest.08-0342
   PubMed Web of Science ®Google Scholar
• Dalal AA, Shah M, Lunacsek O, Hanania NA. Clinical and economic burden of depression/anxiety in chronic obstructive pulmonary disease patients within a managed care population. COPD. 2011;8(4):293–299. doi:10.3109/15412555.2011.586659
   PubMedGoogle Scholar
• Atlantis E, Fahey P, Cochrane B, Smith S. Bidirectional associations between clinically relevant depression or anxiety and COPD: a systematic review and meta-analysis. Chest. 2013;144(3):766–777. doi:10.1378/chest.12-1911
   PubMed Web of Science ®Google Scholar
• Quint JK, Baghai-Ravary R, Donaldson GC, Wedzicha JA. Relationship between depression and exacerbations in COPD. Eur Respir J. 2008;32(1):53–60. doi:10.1183/09031936.00120107
   PubMed Web of Science ®Google Scholar
• Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):648–654. doi:10.1183/09031936.00102509
   PubMed Web of Science ®Google Scholar
• Miyazaki M, Nakamura H, Chubachi S, et al. Analysis of comorbid factors that increase the COPD assessment test scores. Respir Res. 2014;15:13. doi:10.1186/1465-9921-15-13
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Molina J, Quintano JA, et al. Depressive status explains a significant amount of the variance in COPD assessment test (CAT) scores. Int J Chron Obstruct Pulmon Dis. 2018;13:823–831. doi:10.2147/COPD.S154791
   PubMed Web of Science ®Google Scholar
• Marietta von Siemens S, Alter P, Lutter JI, et al. CAT score single item analysis in patients with COPD: results from COSYCONET. Respir Med. 2019;159:105810. doi:10.1016/j.rmed.2019.105810
   PubMed Web of Science ®Google Scholar
• Hilmarsen CW, Wilke S, Engan H, et al. Impact of symptoms of anxiety and depression on COPD Assessment Test scores. Eur Respir J. 2014;43(3):898–900. doi:10.1183/09031936.00163913
   PubMed Web of Science ®Google Scholar
• Silva Junior JL, Conde MB, de Sousa Correa K, da Silva C, da Silva Prestes L, Rabahi MF. COPD Assessment Test (CAT) score as a predictor of major depression among subjects with chronic obstructive pulmonary disease and mild hypoxemia: a case-control study. BMC Pulm Med. 2014;14:186. doi:10.1186/1471-2466-14-186
   PubMed Web of Science ®Google Scholar
• Lee YS, Park S, Oh YM, et al. Chronic obstructive pulmonary disease assessment test can predict depression: a prospective multi-center study. J Korean Med Sci. 2013;28(7):1048–1054. doi:10.3346/jkms.2013.28.7.1048
   PubMed Web of Science ®Google Scholar
• Lim JU, Park CK, Kim T-H, et al. The difficulty of improving quality of life in COPD patients with depression and associated factors. Int J Chron Obstruct Pulmon Dis. 2019;14:2331–2341. doi:10.2147/COPD.S216746
   PubMed Web of Science ®Google Scholar
• Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1(3):385–401. doi:10.1177/014662167700100306
   Web of Science ®Google Scholar
• Higham A, Mathioudakis A, Vestbo J, Singh D. COVID-19 and COPD: a narrative review of the basic science and clinical outcomes. Eur Respir Rev. 2020;29(158):200199. doi:10.1183/16000617.0199-2020
   PubMed Web of Science ®Google Scholar
• Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med. 2017;195(5):557–582. doi:10.1164/rccm.201701-0218PP
   PubMed Web of Science ®Google Scholar
• Singh D, Mathioudakis AG, Higham A. Chronic obstructive pulmonary disease and COVID-19: interrelationships. Curr Opin Pulm Med. 2022;28(2):76–83. doi:10.1097/MCP.0000000000000834
   PubMed Web of Science ®Google Scholar
• Sajjan US. Susceptibility to viral infections in chronic obstructive pulmonary disease: role of epithelial cells. Curr Opin Pulm Med. 2013;19(2):125–132. doi:10.1097/MCP.0b013e32835cef10
   PubMed Web of Science ®Google Scholar
• Wilkinson TMA, Aris E, Bourne S, et al. A prospective, observational cohort study of the seasonal dynamics of airway pathogens in the aetiology of exacerbations in COPD. Thorax. 2017;72(10):919–927. doi:10.1136/thoraxjnl-2016-209023
   PubMed Web of Science ®Google Scholar
• Kahnert K, Lutter JI, Welte T, et al. Impact of the COVID-19 pandemic on the behaviour and health status of patients with COPD: results from the German COPD cohort COSYCONET. ERJ Open Res. 2021;7(3):00242–2021. doi:10.1183/23120541.00242-2021
   PubMedGoogle Scholar
• Santomauro DF, Mantilla Herrera AM, Shadid J; Collaborators C-MD. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet. 2021;398(10312):1700–1712. doi:10.1016/S0140-6736(21)02143-7
   PubMed Web of Science ®Google Scholar
• Wei L, Islam JY, Mascareno EA, Rivera A, Vidot DC, Camacho-Rivera M. Physical and mental health impacts of the COVID-19 pandemic among US adults with chronic respiratory conditions. J Clin Med. 2021;10(17):3981. doi:10.3390/jcm10173981
   PubMed Web of Science ®Google Scholar
• McAuley H, Hadley K, Elneima O, et al. COPD in the time of COVID-19: an analysis of acute exacerbations and reported behavioural changes in patients with COPD. ERJ Open Res. 2021;7(1):00718–2020. doi:10.1183/23120541.00718-2020
   PubMedGoogle Scholar
• Agusti A, Bel E, Thomas M, et al. Treatable traits: toward precision medicine of chronic airway diseases. Eur Respir J. 2016;47(2):410–419. doi:10.1183/13993003.01359-2015
   PubMed Web of Science ®Google Scholar
• Rennard SI, Locantore N, Delafont B, et al. Identification of five chronic obstructive pulmonary disease subgroups with different prognoses in the ECLIPSE cohort using cluster analysis. Ann Am Thorac Soc. 2015;12(3):303–312. doi:10.1513/AnnalsATS.201403-125OC
   PubMed Web of Science ®Google Scholar
• Kunik ME, Roundy K, Veazey C, et al. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest. 2005;127(4):1205–1211. doi:10.1378/chest.127.4.1205
   PubMed Web of Science ®Google Scholar
• Langvik E, Hjemdal O, Nordahl HM. Personality traits, gender differences and symptoms of anhedonia: what does the Hospital Anxiety and Depression Scale (Hads) measure in nonclinical settings? Scand J Psychol. 2016;57(2):144–151. doi:10.1111/sjop.12272
   PubMed Web of Science ®Google Scholar
• Bock K, Bendstrup E, Hilberg O, Lokke A. Screening tools for evaluation of depression in Chronic Obstructive Pulmonary Disease (COPD). A systematic review. Eur Clin Respir J. 2017;4(1):1332931. doi:10.1080/20018525.2017.1332931
   PubMed Web of Science ®Google Scholar
• Alqahtani JS, Oyelade T, Aldhahir AM, et al. Reduction in hospitalised COPD exacerbations during COVID-19: a systematic review and meta-analysis. PLoS One. 2021;16(8):e0255659. doi:10.1371/journal.pone.0255659
   PubMed Web of Science ®Google Scholar
• Berghaus TM, Karschnia P, Haberl S, Schwaiblmair M. Disproportionate decline in admissions for exacerbated COPD during the COVID-19 pandemic. Respir Med. 2022;191:106120. doi:10.1016/j.rmed.2020.106120
   PubMed Web of Science ®Google Scholar
• Rocha V, Jácome C, Martins V, Marques A. Are in Person and Telephone Interviews Equivalent Modes of Administrating the CAT, the FACIT-FS and the SGRQ in People With COPD? Original Research. Front Rehabilit Sci. 2021;2. doi:10.3389/fresc.2021.729190
   PubMedGoogle Scholar